Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

B. P. BIOTRANSPORT ApS FØVLING Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Bankruptcy risk for industry   5.7% 5.7% 5.7% 5.7% 5.7% 5.7% 5.7% 5.7%   Bankruptcy risk   6.9% 4.3% 6.8% 5.1% 4.1% 8.0% 16.7% 16.4%   Credit score (0-100)   36 48 34 42 48 30 10 11   Credit rating   BBB BBB BBB BBB BBB BB BB BB   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   1,007 730 748 895 710 541 0.0 0.0   EBITDA   365 52.0 91.1 253 197 -222 0.0 0.0   EBIT   339 20.6 -58.8 243 188 -233 0.0 0.0   Pre-tax profit (PTP)   332.8 20.5 -142.8 203.8 148.8 -273.3 0.0 0.0   Net earnings   258.9 16.0 -138.3 158.5 115.3 -271.6 0.0 0.0   Pre-tax profit without non-rec. items   333 20.5 -143 204 149 -273 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Tangible assets total   219 221 14.9 12.4 7.6 2.8 0.0 0.0   Shareholders equity total   444 460 272 431 546 274 74.2 74.2   Interest-bearing liabilities   28.6 10.6 12.3 39.4 39.5 36.2 0.0 0.0   Balance sheet total (assets)   682 767 484 694 787 482 74.2 74.2   Net Debt   -164 -273 -243 -334 -298 -50.3 -74.2 -74.2     See the entire balance sheet 1000.0 Volume  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   1,007 730 748 895 710 541 0.0 0.0   Gross profit growth   2,553.1% -27.5% 2.5% 19.7% -20.7% -23.7% -100.0% 0.0%   Employees   3 2 2 2 1 1 0 0   Employee growth %   0.0% -33.3% 0.0% 0.0% -50.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   682 767 484 694 787 482 74 74   Balance sheet change%   26.9% 12.4% -36.9% 43.3% 13.4% -38.8% -84.6% 0.0%   Added value   364.9 52.0 91.1 253.5 198.6 -222.4 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -46 -29 -356 -13 -13 -16 -3 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   1.0 2.0 -1.0 1.0 2.0 -1.0 0.0 0.0   1000.0 Profitability  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   33.7% 2.8% -7.9% 27.2% 26.5% -43.1% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   55.6% 2.8% -9.4% 41.3% 25.4% -36.8% 0.0% 0.0%   ROI %   76.7% 4.4% -15.6% 64.2% 35.5% -52.0% 0.0% 0.0%   ROE %   82.3% 3.5% -37.8% 45.1% 23.6% -66.2% 0.0% 0.0%   1000.0 Solidity  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Equity ratio %   65.1% 60.0% 56.2% 62.1% 69.4% 56.9% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -44.9% -524.3% -266.9% -131.9% -151.3% 22.6% 0.0% 0.0%   Gearing %   6.4% 2.3% 4.5% 9.1% 7.2% 13.2% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   5.0% 0.1% 731.1% 151.9% 99.8% 105.4% 0.0% 0.0%   1000.0 Liquidity  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Quick Ratio   1.9 1.8 2.2 2.6 3.3 2.3 0.0 0.0   Current Ratio   1.9 1.8 2.2 2.6 3.3 2.3 0.0 0.0   Cash and cash equivalent   192.4 283.3 255.5 373.8 337.1 86.5 0.0 0.0   1000.0 Capital use efficiency  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   225.7 239.5 257.1 420.8 539.9 271.4 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   122 26 46 127 199 -222 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   122 26 46 127 197 -222 0 0   EBIT / employee   113 10 -29 122 188 -233 0 0   Net earnings / employee   86 8 -69 79 115 -272 0 0